Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
human-health-solutions
Press Release
Nov 2, 2018
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Three Months Ended 30 September 2018
Parnell delivers 39% revenue growth and a $5.9 million year-to-date improvement in EBITDA as at the third quarter of 2018 compared to the same period in 2017, consolidates the return to profitability, and maintains full-year 2018 guidance at a 35 - 40% increase over 2017 revenue to $26 - $27 million and an EBITDA range of $5.5 - $6.5 million.
Read More
Press Release
Aug 3, 2018
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended 30 June 2018
Parnell delivers 32% revenue growth and a $4.0 million improvement in EBITDA in the first six months of 2018 compared to the same period in 2017, returns to profitability for the first time post-IPO and increases 2018 guidance to a 35% - 40% increase in revenue to $26 - $27 million and an EBITDA range of $5.5 - $6.5 million.
Read More
Press Release
Jul 31, 2018
Parnell Pharmaceuticals Holdings Completes Debt Refinancing With Marathon Asset Management
Read More
First
Prev
1
Next
Last